Sensitivity of whole blood clotting time and activated partial thromboplastin time for factor IX: relevance to gene therapy and determination of post-transfusion elimination time of canine factor IX in hemophilia B dogs

Ítems similars

• CANINE HEMOPHILIA : OBSERVATIONS ON THE COURSE, THE CLOTTING ANOMALY, AND THE EFFECT OF BLOOD TRANSFUSIONS
  per: Graham, John B., et al.
  Publicat: (1949)
• Protein Replacement Therapy and Gene Transfer in Canine Models of Hemophilia A, Hemophilia B, von Willebrand Disease, and Factor VII Deficiency
  per: Nichols, Timothy C., et al.
  Publicat: (2009)
• Improved kinetics of rIX-FP, a recombinant fusion protein linking factor IX with albumin, in cynomolgus monkeys and hemophilia B dogs
  per: Nolte, M. W., et al.
  Publicat: (2012)
• Poly-N-Acetylglucosamine Fibers Amplify the Effectiveness of Recombinant Factor VIIA on Clot Formation in Hemophilia B Canine Blood
  per: Fischer, Thomas H., et al.
  Publicat: (2011)
• Soy phosphatidylinositol containing lipid nanoparticle prolongs the plasma survival and hemostatic efficacy of B-domain deleted recombinant canine Factor VIII in Hemophilia A dogs
  per: Shetty, Krithika A., et al.
  Publicat: (2016)